TrialArchives of gynecology and obstetrics2023

Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics.

Giovanni Grandi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.